Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Nelson

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Diabetes Research and Clinical Practice|June 21, 2023
Effect of vitamin D on regression to normal glucose regulation and individual glycemic measures: A secondary analysis among participants adherent to the trial protocol in the randomized clinical trial vitamin D and type 2 diabetes (D2d) studyDaniel S Hsia, Jason Nelson, Ellen M Vickery, et al.
Diabetes Care|October 6, 2020
Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) StudyBess Dawson-Hughes, Myrlene A Staten, William C Knowler, et al.
European Journal of Nutrition|November 4, 2015
Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention ProgramLisa Ceglia, Jason Nelson, James Ware, et al.
Journal of the American Heart Association|December 24, 2022
Association of Incidentally Discovered Covert Cerebrovascular Disease Identified Using Natural Language Processing and Future DementiaDavid M Kent, Lester Y Leung, Yichen Zhou, et al.
BMJ Open Diabetes Research & Care|February 20, 2025
Role of 2-hour plasma glucose in assessing pre-diabetes risk: insights from the vitamin D and type 2 diabetes (D2d) study cohortSun H Kim, Vanita R Aroda, Ranee Chatterjee, et al.
BMC Neurology|May 12, 2021
Agreement between neuroimages and reports for natural language processing-based detection of silent brain infarcts and white matter diseaseLester Y Leung, Sunyang Fu, Patrick H Luetmer, et al.
The American Journal of Clinical Nutrition|March 31, 2023
Effect of intratrial mean 25(OH)D concentration on diabetes risk, by race and weight: an ancillary analysis in the D2d studyRanee Chatterjee, Clemontina A Davenport, Ellen M Vickery, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 7, 2023
Stratifying Future Stroke Risk with Incidentally- Discovered White Matter Disease Severity and Covert Brain Infarct SiteAndy Y Wang, Lester Y Leung, Eric J Puttock, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 27, 2022
Stratifying Future Stroke Risk with Incidentally Discovered White Matter Disease Severity and Covert Brain Infarct SiteAndy Y Wang, Lester Y Leung, Eric J Puttock, et al.
European Journal of Clinical Nutrition|April 14, 2022
Correction to: Safety and tolerability of high-dose daily vitamin D<sub>3</sub> supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetesKaren C Johnson, Anastassios G Pittas, Karen L Margolis, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Diabetes Research and Clinical Practice|June 21, 2023
Effect of vitamin D on regression to normal glucose regulation and individual glycemic measures: A secondary analysis among participants adherent to the trial protocol in the randomized clinical trial vitamin D and type 2 diabetes (D2d) studyDaniel S Hsia, Jason Nelson, Ellen M Vickery, et al.
Diabetes Care|October 6, 2020
Intratrial Exposure to Vitamin D and New-Onset Diabetes Among Adults With Prediabetes: A Secondary Analysis From the Vitamin D and Type 2 Diabetes (D2d) StudyBess Dawson-Hughes, Myrlene A Staten, William C Knowler, et al.
European Journal of Nutrition|November 4, 2015
Association between body weight and composition and plasma 25-hydroxyvitamin D level in the Diabetes Prevention ProgramLisa Ceglia, Jason Nelson, James Ware, et al.
Journal of the American Heart Association|December 24, 2022
Association of Incidentally Discovered Covert Cerebrovascular Disease Identified Using Natural Language Processing and Future DementiaDavid M Kent, Lester Y Leung, Yichen Zhou, et al.
BMJ Open Diabetes Research & Care|February 20, 2025
Role of 2-hour plasma glucose in assessing pre-diabetes risk: insights from the vitamin D and type 2 diabetes (D2d) study cohortSun H Kim, Vanita R Aroda, Ranee Chatterjee, et al.
BMC Neurology|May 12, 2021
Agreement between neuroimages and reports for natural language processing-based detection of silent brain infarcts and white matter diseaseLester Y Leung, Sunyang Fu, Patrick H Luetmer, et al.
The American Journal of Clinical Nutrition|March 31, 2023
Effect of intratrial mean 25(OH)D concentration on diabetes risk, by race and weight: an ancillary analysis in the D2d studyRanee Chatterjee, Clemontina A Davenport, Ellen M Vickery, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 7, 2023
Stratifying Future Stroke Risk with Incidentally- Discovered White Matter Disease Severity and Covert Brain Infarct SiteAndy Y Wang, Lester Y Leung, Eric J Puttock, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 27, 2022
Stratifying Future Stroke Risk with Incidentally Discovered White Matter Disease Severity and Covert Brain Infarct SiteAndy Y Wang, Lester Y Leung, Eric J Puttock, et al.
European Journal of Clinical Nutrition|April 14, 2022
Correction to: Safety and tolerability of high-dose daily vitamin D<sub>3</sub> supplementation in the vitamin D and type 2 diabetes (D2d) study-a randomized trial in persons with prediabetesKaren C Johnson, Anastassios G Pittas, Karen L Margolis, et al.
Pageof 8